Eslicarbazepine Acetate Tablet
Product Images NDC 31722-430

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Eslicarbazepine Acetate (NDC 31722-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Eslicarbazepine-tablets-200mg-30s-container (Eslicarbazepine Tablets 200mg 30s Container)

Eslicarbazepine-tablets-200mg-30s-container (Eslicarbazepine Tablets 200mg 30s Container)
This is a description for a medication called Eslicarbazepine Acetate Tablets. Each tablet contains 200 mg of eslicarbazepine acetate. It is recommended to dispense the Medication Guide to each patient along with the medication. The usual dosage information can be found in the package insert. The tablets should be stored at a temperature of 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). It is important to keep the bottle tightly closed and out of reach of children. The medication is manufactured for Camber Pharmaceuticals, Inc. by Hetero Labs Limited in India. Additionally, the contact number for the U.S. is provided as 1-866-495-1995.*
FDA Label Image

Eslicarbazepine-tablets-400mg-30s-container (Eslicarbazepine Tablets 400mg 30s Container)

Eslicarbazepine-tablets-400mg-30s-container (Eslicarbazepine Tablets 400mg 30s Container)
This text appears to be a description of a medication called "Eslicarbazepine Acetate Tablets". The medication is dispensed in the form of 400mg tablets and is meant to be taken once daily. The accompanying medication guide should be provided to each patient by the pharmacist. The usual dosage information can be found in the package insert. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication should be kept tightly closed and out of reach of children. The manufacturer is Hetero Labs Limited, located in India. The medication is manufactured for Camber Pharmaceuticals, Inc.*
FDA Label Image

Eslicarbazepine-tablets-600mg-60s-container (Eslicarbazepine Tablets 600mg 60s Container)

Eslicarbazepine-tablets-600mg-60s-container (Eslicarbazepine Tablets 600mg 60s Container)
This is a description for Eslicarbazepine Acetate Tablets. Each tablet contains 600mg of eslicarbazepine acetate. The usual dosage information can be found in the package insert. The tablets should be stored at a temperature between 20°C and 25°C, with excursions permitted between 15°C and 30°C. The medication should be kept tightly closed and out of reach of children. For any inquiries, the U.S. contact number is 1-866-495-1995. The tablets are manufactured by Hetero Labs Limited in India for Camber Pharmaceuticals, Inc.*
FDA Label Image

Eslicarbazepine-tablets-600mg-90s-container (Eslicarbazepine Tablets 600mg 90s Container)

Eslicarbazepine-tablets-600mg-90s-container (Eslicarbazepine Tablets 600mg 90s Container)
This is a description of a medication called Eslicarbazepine Acetate Tablets. Each tablet contains 600 mg of eslicarbazepine acetate. The medication is meant to be taken once daily. The pharmacist is instructed to dispense the accompanying Medication Guide to each patient. It is important to store the tablets at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication should be kept tightly closed and out of reach of children. The manufacturer of this medication is HETERO, produced in India for Camber Pharmaceuticals, Inc, based in Piscataway, NJ, USA. The U.S. contact number provided is 1-866-495-1995.*
FDA Label Image

Eslicarbazepine-tablets-800mg-30s-container (Eslicarbazepine Tablets 800mg 30s Container)

Eslicarbazepine-tablets-800mg-30s-container (Eslicarbazepine Tablets 800mg 30s Container)
This is a description of a medication called "Eslicarbazepine Acetate Tablets" with a strength of 800 mg. It is to be taken once daily as directed. The medication is manufactured by Hetero Labs Limited in India and distributed by Camber Pharmaceuticals, Inc. The package contains 30 tablets. The pharmacist is instructed to dispense the accompanying Medication Guide to each patient. The usual dosage information can be found in the package insert. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It is important to keep the medication tightly closed and out of reach of children. The U.S. contact number for any inquiries is 1-866-495-1995.*
FDA Label Image

Eslicarbazepine-tablets-800mg-90s-container (Eslicarbazepine Tablets 800mg 90s Container)

Eslicarbazepine-tablets-800mg-90s-container (Eslicarbazepine Tablets 800mg 90s Container)
This is a description of a medication called Eslicarbazepine Acetate Tablets. Each tablet contains 800 mg of eslicarbazepine acetate. The recommended dosage can be found in the package insert. It should be stored at a temperature of 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medicine should be kept tightly closed and out of reach of children. For any inquiries, the U.S. contact number is 1-866-495-1995. The medication is manufactured by Hetero Labs Limited in India and distributed by Camber Pharmaceuticals, Inc. in Piscataway, NJ. A medication guide should be dispensed to each patient by the pharmacist.*
FDA Label Image

Eslicarbazipinetabletsfigure1 (Eslicarbazipinetabletsfigure1)

FDA Label Image

Eslicarbazipinetabletsfigure2 (Eslicarbazipinetabletsfigure2)

Eslicarbazipinetabletsfigure2 (Eslicarbazipinetabletsfigure2)
Change due to Fold Change and 90% Confidence Interval (CI) Recommendation: Carbamazepine may need a dose adjustment as mentioned in section 2.3. Gabapentin - None Lamotrigine - None Levetiracetam - None Phenobarbital may need a higher dose of eslicarbazepine cetate as explained in section 2.3. Phenytoin may need a higher dose of eslicathazepine acetate as mentioned in section 2.3. Topiramate - None Valproate - None Note: Phenobarbital and/or phenobarbital-like antiepileptic drugs (e.g., primidone)*
FDA Label Image

Eslicarbazipinetabletsfigure3 (Eslicarbazipinetabletsfigure3)

FDA Label Image

Eslicarbazipinetabletsfigure4 (Eslicarbazipinetabletsfigure4)

FDA Label Image

Eslicarbazipinetabletsfigure5 (Eslicarbazipinetabletsfigure5)

FDA Label Image

Eslicarbazipinetabletsfigure6 (Eslicarbazipinetabletsfigure6)

FDA Label Image

Eslicarbazipinetabletsstructure (Eslicarbazipinetabletsstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.